Rhumbline Advisers trimmed its stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 4....
Voyager Therapeutics (NASDAQ:VYGR – Get Free Report) and Prime Medicine (NYSE:PRME – Get Free Report...
Voyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) - Investment analysts at Cantor Fitzgerald is...
LEXINGTON, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a bio...
Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR - Get Free Report) have received an average recomm...